© 2001 by Oxford University Press
Journal of the National Cancer Institute, Vol. 93, No. 9, 676-677,
May 2, 2001
© 2001 Oxford University Press
NEWS |
Awards, Appointment, Announcements
V. Craig Jordan, Ph.D., D.Sc., received the 24th Annual Bristol-Myers Squibb Award for Distinguished Achievement in Cancer Research. Jordan received the $50,000 cash prize and a silver medallion at a dinner in his honor in New York City in April.
|
Jordan is the Diana, Princess of Wales Professor of Cancer Research and director of the Lynn Sage Breast Cancer Research Program at the Robert H. Lurie Comprehensive Cancer Center and Professor of Molecular Pharmacology and Biological Chemistry at Northwestern University Medical School in Chicago.
He was selected for the award by an independent, international committee of leading cancer investigators, all of whom are principal investigators of unrestricted cancer research grants from the Bristol-Myers Squibb Foundation. He was honored for his research on the clinical use of antiestrogens and selective estrogen receptor modulators.
Officers Elected
Richard J. O’Reilly, M.D., chair of the Department of Pediatrics and chief of the Bone Marrow Transplant Service at Memorial Sloan-Kettering Cancer Center in New York, has been installed as president of the American Society for Blood and Marrow Transplantation.
Joseph H. Antin, M.D., chief of the Adult Stem Cell Transplant Program at Dana-Farber Cancer Center, Boston, was elected ASBMT vice president, to become president in 2003.
Others winning office in a mail ballot among ASBMT members in February were: secretary, Daniel J. Wiesdorf, M.D., University of Minnesota, Minneapolis; director, Andrew L. Pecora, M.D., Hackensack University Medical Center, Hackensack, N.J.; director, Catherine Verfaillie, M.D., University of Minnesota, Minneapolis; director, Edward D. Ball, M.D., University of California at San Diego.
Assuming the office of president-elect was John R. Wingard, M.D., director of the Bone Marrow Transplant Program at the University of Florida College of Medicine in Gainesville.
Chair Established
The Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill’s School of Medicine has established a $1.5 million G. Denman Hammond, M.D., Chair in Childhood Cancer.
Hammond is the founding president and chief executive officer of the National Childhood Cancer Foundation.
The professorship was made possible by an anonymous donor in honor of Hammond. A national recruitment for the endowed chair appointment will begin this summer.
Reaman Elected
Gregory H. Reaman, M.D., has been elected as the first group chair of the Children’s Oncology Group, a new clinical trials cooperative research group.
|
Reaman, professor of pediatrics at the George Washington University School of Medicine and Health Sciences, Washington, D.C., serves as the executive director of the Center for Cancer and Blood Disorders and as chair of the Division of Hematology-Oncology at the Children’s National Medical Center in Washington, D.C.
The Children’s Oncology Group will submit its first competing grant application to the National Cancer Institute in February 2002.
Langer Honored
The Society of Surgical Oncology has awarded Amy S. Langer its James Ewing Layman Award.
|
The award is given annually to a non-physician who has made a contribution to improving the care of cancer patients.
Langer, executive director of the National Alliance of Breast Cancer Organizations, also serves on the Board of Scientific Advisors of the National Cancer Institute, the Breast Cancer Committee of the NCI-led cooperative clinical trials research intergroup, and the National Cancer Legislation Advisory Committee.
Lema Named
Mark J. Lema, M.D., Ph.D., has been named president of the New York State Society of Anesthesiologists Inc., a chapter of the Society of Anesthesiologists.
Lema is the chairman of the Department of Anesthesiology and Pain Medicine at Roswell Park Cancer Institute, Buffalo, N.Y. He is also a professor of anesthesiology and interim chair of the Department of Anesthesiology at the University at Buffalo School of Medicine and Biomedical Sciences and associate research professor of its Experimental Pathology Program.
Gordon Appointed
BioStratum Inc., Research Triangle Park, N.C., has appointed Gary M. Gordon, M.D., as its vice president of business development.
Prior to joining BioStratum, Gordon held several senior-level positions with Sentinel Biosciences, a subsidiary of Roche, and Genelabs Technologies Inc.
BioStratum develops drugs that focus on the basal lamina’s central role in many diseases.
Zimmer Named
Deltagen Inc., Menlo Park, Calif., appointed Erick J. Zimmer as director of commercial development.
Zimmer was previously senior manager in the Parmaceutical Products division at Abbott Laboratories in Chicago.
Deltagen is a genomics and biotechnology company that provides data to pharmaceutical and biotechnology companies on the function, role, and disease relevance of mammalian genes.
Nominations Sought
Nominations are being sought for the first Paul Marks Prizes for Cancer Research. The prizes will recognize significant discoveries made by outstanding investigators up to the age of 45 at the time of the award.
Up to five investigators will share the cash award of $125,000. The awards are named for Paul Marks, M.D., president emeritus of Memorial Sloan-Kettering Cancer Center, New York.
Nominations must be received by July 1, 2001, and should be sent to Linda Stevenson, Director, Research and Training Administration, Box 399, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||